Skip to content

IBB

iShares Biotechnology ETF

$205.39−1.58 (−0.76%)Close Nov 18, 2026

Adjusted price

+23.63% total return, past year

Key statistics

Expense ratio
0.44%
52-week range
$160.41$221.13
All-time high close
$221.13 on Nov 4, 2026
From all-time high
−7.12%
Max drawdown
−62.85%
Volatility
25.92%
Sharpe ratio
0.40
Beta (5Y monthly)
0.72

Total

1M
+1.68%
YTD
+21.81%
1Y
+23.63%

Per year

3Y
+20.54%
5Y
+6.24%
10Y
+8.30%
20Y
+10.86%
Since 2001
+7.35%

Fund facts

As of Jun 30, 2026
Net assets
$9.09B
Holdings
252
Top 10 holdings
54.3%
Stocks
99.9%
Cash
12.0%

Sectors

Health Care
99.5%
Other
0.4%

Top holdings

HoldingWeight (%)
BlackRock Funds III11.7
VRTXVertex Pharmaceuticals Incorporated8.1
AMGNAmgen Inc.7.8
GILDGilead Sciences, Inc.6.8
REGNRegeneron Pharmaceuticals, Inc.4.9
ARGXargenx SE3.8
ALNYAlnylam Pharmaceuticals, Inc.3.1
NTRANatera, Inc.2.9
RVMDRevolution Medicines, Inc.2.8
BIIBBiogen Inc.2.5